Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-27 09:57:48 - browse：9198

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide, the company said Tuesday.

Biogen’s chief executive, Christopher A. Viehbacher, said as the firm released fourth-quarter earnings that he had expected the slow uptake and sees considerable demand for the medication. He told reporters that 3,800 patients with early-stage Alzheimer’s have signed up on multiple registries to receive the drug, called Leqembi, as of last month.

Before patients can get the drug, which costs $26,500-a-year, they must undergo a brain scan or a spinal tap to confirm that they have build-up of deposits of a sticky toxic protein called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： States should stop sabotaging methadone treatment reform

WSS

Colorectal cancer study finds potential in overlooked immune cell

The future of health care in the House

FDA authorizes Novavax’s updated Covid

Liquid biopsy for lung cancer is launched by Delfi

Chan Zuckerberg Biohub Chicago to focus on inflammation

Liquid biopsy for lung cancer is launched by Delfi

hotspot

Wikipedia

explore

Affirmative action in medical school literally saved lives

Readout Newsletter: Merck, Vertex, and Viking updates

New air purifier tech could be key to improving indoor air quality

Sana to lay off nearly a third of staff, de

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Abortion pill Supreme Court ruling could impact entire drug industry

Cancer drug shortages should be causing more outrage

Physician executives need more than on

Medicare proposal to cover medical devices draws a mixed reaction

Bill would stop addiction treatment from triggering child abuse inquiry

Wikipedia

Why the world’s most expensive drug might be worth the price

Scientists boost immune system in aging mice by making it youthful

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Decaf coffee targeted by food safety group under obscure FDA rule

Donor acceptance rates hint at racial, gender bias in heart transplants: study

hotspot

focus

leisure time

Wikipedia